Posts By Alex
-
941Wire StoriesMori Memorial Foundation�s GPCI-2021 Report: COVID-19 Creates Challenges and Opportunities for Cities
TOKYO–(BUSINESS WIRE)–London, New York, Tokyo, Paris and Singapore once again emerged in that order as the world�s most comprehensively attractive cities in...
-
553Wire Stories
Best�s Market Segment Report: AM Best Maintains Stable Outlook on Taiwan�s Non-Life Insurance Market
HONG KONG–(BUSINESS WIRE)–#insurance—AM Best is maintaining a stable market segment outlook on Taiwan�s non-life insurance segment, citing robust underwriting and investment performance...
-
544Wire Stories
VeriSilicon Image Signal Processor IP Achieved ISO 26262 Automotive Functional Safety Certification
The awarded certificate accelerates VeriSilicon�s strategic deployment in autonomous driving and the automotive segment in general SHANGHAI–(BUSINESS WIRE)–#AI–VeriSilicon (688521.SH), a leading Silicon...
-
657Wire Stories
Hagens Berman: Sun and Ranbaxy Facing January Trial as Federal Judge Denies Summary Judgment in Generic Drug Overpricing Lawsuit
Attorneys will take antitrust case to trial in January 2022 BOSTON–(BUSINESS WIRE)–#antitrust–Yesterday, a federal judge denied all motions for summary judgment in...
-
626Wire Stories
Takeda�s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies
– In the Phase 3 SOLSTICE study, more than twice the proportion of adult transplant recipients with refractory or resistant (R/R) CMV...
-
570Wire Stories
EBR Systems Raises AU$110M in Initial Public Offering on the Australian Securities Exchange (ASX)
EBR Systems� WiSE� CRT System is world�s first and only wireless endocardial (inside the heart) left ventricle pacing system for heart failure...
-
570Wire Stories
BeiGene Announces Approval of BRUKINSA (zanubrutinib) in the European Union for Treatment of Adults with Waldenstr�m�s Macroglobulinemia
EU approval follows recent approvals for BRUKINSA including U.S., China, Brazil, and Canada The approval is based on Phase 3 ASPEN head-to-head...
-
581Wire Stories
Republic of Palau Partners with Ripple to Develop Digital Currency Strategy
Palau to explore using the XRP Ledger to create world�s first government-issued national stablecoin SAN FRANCISCO & NGERULMUD, Palau–(BUSINESS WIRE)–Ripple, the leading...
-
605Wire Stories
Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial in China of GlycoMimetics� Uproleselan for the Treatment of AML
ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that Apollomics has dosed the first patient in China in a Phase 3 clinical...
-
559Wire Stories
ALSP Orchid Acquisition Corporation I Announces $172.5 Million Initial Public Offering
SEATTLE–(BUSINESS WIRE)–ALSP Orchid Acquisition Corporation I (NASDAQ: ALORU) (the �Company� or �ALSP Orchid�) today announced that it has closed its initial public...
